← Back to home

Locoregionally advanced head and neck squamous cell carcinoma (la-HNSCC)

Clinical trials for Locoregionally advanced head and neck squamous cell carcinoma (la-HNSCC) explained in plain language.

Never miss a new study

Get alerted when new Locoregionally advanced head and neck squamous cell carcinoma (la-HNSCC) trials appear

Sign up with your email to follow new studies for Locoregionally advanced head and neck squamous cell carcinoma (la-HNSCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New drug aims to wipe out lingering cancer DNA after standard treatment

Disease control Recruiting now

This phase 2 study tests a drug called AZD2936 in people with high-risk head and neck cancer who still have traces of cancer DNA in their blood after completing standard treatment. The drug is designed to boost the immune system to find and destroy these remaining cancer cells. A…

Matched conditions: LOCOREGIONALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA (LA-HNSCC)

Phase 2 • Sponsor: University Health Network, Toronto • Aim: Disease control

Last updated Jun 27, 2026 09:08 UTC

Locoregionally advanced head and neck squamous cell carcinoma (la-HNSCC)

Get alerted when new Locoregionally advanced head and neck squamous cell carcinoma (la-HNSCC) trials appear

New drug aims to wipe out lingering cancer DNA after standard treatment